Title | A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia |
Protocole ID | BGB-11417-301 |
ClinicalTrials.gov ID | NCT06073821 |
Cancer Type(s) | Chronic Lymphocytic Leukemia |
Phase | Phase III |
Stage | |
Study Type | Clinical |
Drug | Sonrotoclax + zanubrutinib comparé à vénétoclax + obinutuzumab |
Institution |
CISSS DE LA MONTEREGIE-CENTRE
HOPITAL CHARLES-LE MOYNE 3120 boulevard Taschereau, Greenfield Park, QC, J4V2H1 |
City | |
Principal Investigator |
Dr. Mélina Boutin |
Coordinator |
Fanny Raquepas Trudel 450-466-5000 poste 3593 |
Status | Recruiting |
Activation Date | |
Eligibility Criteria |
|
Exclusion Criteria |
|